SCHEMBL5846509

SCHEMBL5846509

O=C(O)COc1cccc(C(=O)O)c1OCC(=O)O

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.53
KDM4E B2RXH2 4/20 0.53
ALDH1A1 P00352 4/20 0.53
HPGD P15428 2/20 0.53
HTT P42858 1/20 0.53
TDP1 Q9NUW8 1/20 0.53
CD69 Q07108 3/20 0.51
L3MBTL1 Q9Y468 2/20 0.51
POLB P06746 1/20 0.51
SMN1; SMN2 Q16637 1/20 0.51
GLA P06280 1/20 0.51
FABP3 P05413 2/20 0.50
FABP4 P15090 2/20 0.50
FABP5 Q01469 2/20 0.50
PTGDR2 Q9Y5Y4 1/20 0.49
MAPK1 P28482 1/20 0.49
CASP1 P29466 1/20 0.46
HSD17B10 Q99714 1/20 0.46
PTK2B Q14289 1/20 0.46
ALOX15 P16050 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20509584 0.89 KMT2A (0.60) KMT2AKDM4EALDH1A1HPGDHTT
SCHEMBL7824239 0.88 KDM4E (0.60) KMT2AKDM4EALDH1A1HPGDHTT
SCHEMBL1145948 0.87 KMT2A (0.62) KMT2AKDM4EALDH1A1HPGDTDP1
SCHEMBL8414412 0.83 PTGDR2 (0.57) KMT2AKDM4EALDH1A1HPGDHTT
SCHEMBL29502958 0.83 KDM4E (0.73) KMT2AKDM4EALDH1A1HPGDHTT
SCHEMBL341639 0.83 KDM4E (0.73) KMT2AKDM4EALDH1A1HPGDHTT
SCHEMBL7527833 0.81 ABCB1 (0.56) KDM4EALDH1A1HPGDHTTL3MBTL1
SCHEMBL6563571 0.81 KDM4E (0.65) KMT2AKDM4EALDH1A1HPGDHTT
SCHEMBL20509554 0.81 ALDH1A1 (0.60) KMT2AKDM4EALDH1A1HPGDCD69
SCHEMBL28731750 0.81 KMT2A (0.77) KMT2AKDM4EALDH1A1HTTTDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050014951-A1 Photoprotective and lightfastness-enhancing siloxanes XEROX CORPORATION 2005-01-20 US claimed
US-6803395-B2 POLYSILOXANE HAVING THEREON A HYDROPHILIC MOIETY AND A LIGHTFASTNESS MOIETY XEROX CORPORATION 2004-10-12 US claimed
US-20030137570-A1 Photoprotective and lightfastness-enhancing siloxanes XEROX CORPORATION 2003-07-24 US claimed
US-20030133886-A1 Photoprotective and lightfastness-enhancing siloxanes XEROX CORPORATION 2003-07-17 US claimed
US-20030119940-A1 Ink composition with improved lightfastness XEROX CORPORATION 2003-06-26 US claimed
US-6569511-B1 Polysiloxane having a hydrophilic moiety and a lightfastness moiety; ink jet coating XEROX CORPORATION 2003-05-27 US claimed
US-7074853-B2 Photoprotective and lightfastness-enhancing siloxanes XEROX CORPORATION (US) 2006-07-11 US disclosed
US-6861458-B2 Photoprotective and lightfastness-enhancing siloxanes XEROX CORPORATION (US) 2005-03-01 US disclosed
US-20050014951-A1 Photoprotective and lightfastness-enhancing siloxanes XEROX CORPORATION 2005-01-20 US disclosed
US-6803395-B2 POLYSILOXANE HAVING THEREON A HYDROPHILIC MOIETY AND A LIGHTFASTNESS MOIETY XEROX CORPORATION 2004-10-12 US disclosed
US-20030137570-A1 Photoprotective and lightfastness-enhancing siloxanes XEROX CORPORATION 2003-07-24 US disclosed
US-20030133886-A1 Photoprotective and lightfastness-enhancing siloxanes XEROX CORPORATION 2003-07-17 US disclosed
US-20030119940-A1 Ink composition with improved lightfastness XEROX CORPORATION 2003-06-26 US disclosed
US-6248766-B1 CARDIOVASCULAR DISORDERS TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2001-06-19 US disclosed
US-5686633-A PHOTOSTABILIZERS CIBA SPECIALTY CHEMICALS CORPORATION (US) 1997-11-11 US disclosed
EP-0373574-B1 Inks, especially for ink jet printing CIBA GEIGY AG (CH) 1994-09-14 EP disclosed
EP-0373573-B1 Recording material for ink jet printing CIBA GEIGY AG (CH) 1994-06-22 EP disclosed
US-5098477-A Aromatic ether derivatives as light stabilizers for organic materials CIBA-GEIGY CORPORATION (US) 1992-03-24 US disclosed
US-5073448-A Containing light stabilizers CIBA-GEIGY CORPORATION (US) 1991-12-17 US disclosed
EP-0373574-A1 Inks, especially for ink jet printing CIBA-GEIGY AG (CH) 1990-06-20 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050014951-A1 Photoprotective and lightfastness-enhancing siloxanes LRRFIP1, LRRC59, MMS19 KMT2A 1571/4885KDM4E 1625/4885ALDH1A1 656/4885
US-20030133886-A1 Photoprotective and lightfastness-enhancing siloxanes ITGA1, ITGB1, ITGB8 KMT2A 1558/4885KDM4E 1482/4885ALDH1A1 443/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.